ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ONVO Organovo Holdings Inc

0.96
-0.11 (-10.28%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Organovo Holdings Inc NASDAQ:ONVO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.11 -10.28% 0.96 0.9332 1.00 1.02 0.9305 0.98 385,734 01:00:00

Current Report Filing (8-k)

16/05/2014 11:03am

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 16, 2014

 

 

ORGANOVO HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

Commission File Number: 001-35996

 

Delaware   27-1488943

(State or other jurisdiction

of incorporation)

 

(I.R.S. Employer

Identification No.)

6275 Nancy Ridge Dr.,

San Diego, California 92121

(Address of principal executive offices, including zip code)

(858) 550-9994

(Registrant’s telephone number, including area code)

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 7.01 Regulation FD Disclosure

On May 16, 2014, Organovo Holdings, Inc. (the “Company”) announced that in response to investor inquiries it has updated the “Investor” section of its website, including the section titled “Investor FAQ” located at http://www.organovo.com/investors/frequently-asked-questions.

The Company also has provided additional detail on insider transactions disclosed via Section 16 filings, available at http://www.organovo.com/sites/default/files/assets/Organovo_Section_16_Disclosure_List_2014-05-14.pdf.

The information furnished on this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ORGANOVO HOLDINGS, INC.
Date: May 16, 2014  

/s/ Keith Murphy

  Keith Murphy
  Chief Executive Officer

1 Year Organovo Chart

1 Year Organovo Chart

1 Month Organovo Chart

1 Month Organovo Chart

Your Recent History

Delayed Upgrade Clock